Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03905148 |
| Title | Study of the Safety and Pharmacokinetics of BGB-283 (Lifirfenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | BeiGene |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California Los Angeles | RECRUITING | Santa Monica | California | 90404 | United States | Details |
| MD Anderson | RECRUITING | Houston | Texas | 77030 | United States | Details |
| Blacktown Cancer and Haematology Centre | RECRUITING | Blacktown | New South Wales | 2148 | Australia | Details |
| The Prince of Wales Private Hospital - Specialist Medical Randwick | RECRUITING | Randwick | New South Wales | 2031 | Australia | Details |
| Peter MacCallum Cancer Centre | RECRUITING | Melbourne | Victoria | 3000 | Australia | Details |
| Linear Clinical Research | RECRUITING | Nedlands | Western Australia | 6009 | Australia | Details |